Intravenous azithromycin as salvage therapy in a patient with Legionnaire's disease
- 1 June 1994
- Vol. 49 (6) , 620-621
- https://doi.org/10.1136/thx.49.6.620
Abstract
A patient with proven Legionnaire's disease is described whose clinical condition improved with intravenous azithromycin after failure to respond to treatment with erythromycin and rifampicin.Keywords
This publication has 8 references indexed in Scilit:
- A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infectionsJournal of Antimicrobial Chemotherapy, 1993
- The pharmacokinetics of azithromycin in human serum and tissuesJournal of Antimicrobial Chemotherapy, 1990
- Comparison of azithromycin and erythromycin in the treatment of atypical pneumoniasJournal of Antimicrobial Chemotherapy, 1990
- Efficacy of azithromycin in the treatment of guinea pigs infected with Legionella pneumophila by aerosolJournal of Antimicrobial Chemotherapy, 1990
- Sensitivity and resistance of Legionella pneumophila to some antibiotics and combinations of antibioticsJournal of Antimicrobial Chemotherapy, 1988
- Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organismsAntimicrobial Agents and Chemotherapy, 1987
- Failure of erythromycin/rifampicin treatment of legionella pneumoniaJournal of Infection, 1985
- Diagnosis of Legionnaires' disease. An update of laboratory methods with new emphasis on isolation by cultureJAMA, 1983